Gateway Biotechnology Pipeline
| Drug | Indication | Phase |
|---|
| GW-TT1 | Noise-induced & Age-related Hearing Loss Prevention | Pre-clinical |
| GW-TT2 | Recent-onset Tinnitus; Hearing Loss in SSNHL & Ménière's disease | Phase 1 |
| GW-TT3 | Severe Debilitating Tinnitus | Pre-clinical |
| GW-TT5 | Severe Chronic Tinnitus | Discovery |